The medical insurance department has crossed the hospital, and the scope of direct payment to pharmaceutical companies is expanding. Will it affect the hospital?

This will definitely have an impact on the hospital, and the operating scope of the hospital will become smaller and smaller. In the past, people were settled by hospitals and pharmaceutical companies, and medical insurance was settled by hospitals. However, with the development of society, some areas began to pilot the direct settlement from medical insurance to pharmaceutical companies, which will have a significant impact on pharmaceutical companies and hospitals.

The medical insurance department crosses hospitals, and the scope of direct payment to pharmaceutical companies is expanding? Some parts of the country have changed the settlement method of medical insurance-hospital-pharmaceutical companies, and the medical insurance department directly crosses hospitals, and the scope of payment to pharmaceutical companies is expanding.

Ningxia Medical Insurance Bureau, Xiamen Medical Insurance Bureau, Municipal Health and Health Commission and Market Supervision Administration issued documents respectively, proposing that medical consumables purchased in the medical insurance catalogue should be included in the direct settlement scope of medical insurance to ensure timely settlement. Shandong, Shaanxi, Guizhou, Tianjin, Liaoning and other places have also carried out pilot projects to promote direct settlement between medical insurance funds and pharmaceutical companies.

This has a great impact on the hospital. Medical insurance will be directly settled with pharmaceutical companies, which has a great impact on hospitals. The impact is mainly reflected in two aspects: one is to affect the hospital's financial situation, and the other is to reduce the hospital's income.

First, the impact of hospital capital turnover

In the past, in the process of hospital capital turnover, the settlement cycle of medical insurance was longer, and the settlement cycle between hospitals and pharmaceutical companies was also longer. In the whole process, the hospital itself has strong operability, which can effectively affect the flow of funds, play a great role in the hospital's capital turnover, and even affect the hospital doctors' choice of drugs in some cases.

Medical insurance is directly settled with pharmaceutical companies, and there will definitely be some problems in the hospital's capital turnover, and the hospital's financial pressure will also increase, which may affect the overall operation of the hospital.

Second, the hospital's income has decreased.

It has been several years since the country has implemented zero drug addition, and it is unprofitable for hospitals to sell drugs, but hospitals still need to bear the cost of drug procurement and the salary cost of managers. This in itself has brought some pressure to the operation of the hospital. In the past, the settlement period was long, which allowed the hospital to have more turnover space and could collect money by other means.

However, after the direct settlement of medical insurance and pharmaceutical companies, the hospital's income may be further reduced, and the cash flow will inevitably be more tense.

Before implementing such a big policy, the state must have relevant considerations. Maybe the hospital will experience pain in a short time, but I believe that the whole medical industry will have a more stable development in the future.